Does ENZALUTAMIDE Cause Neuropathy peripheral? 562 Reports in FDA Database
Prostate Health & Male Vitality — Naturally
ProstaVive: better flow, better sleep, better energy. 180-day guarantee.
According to the FDA Adverse Event Reporting System (FAERS), 562 reports of Neuropathy peripheral have been filed in association with ENZALUTAMIDE (Xtandi). This represents 1.1% of all adverse event reports for ENZALUTAMIDE.
562
Reports of Neuropathy peripheral with ENZALUTAMIDE
1.1%
of all ENZALUTAMIDE reports
28
Deaths
54
Hospitalizations
How Dangerous Is Neuropathy peripheral From ENZALUTAMIDE?
Of the 562 reports, 28 (5.0%) resulted in death, 54 (9.6%) required hospitalization, and 2 (0.4%) were considered life-threatening.
Is Neuropathy peripheral Listed in the Official Label?
This adverse event is not currently listed in the official FDA drug label for ENZALUTAMIDE. However, 562 reports have been filed with the FAERS database.
What Other Side Effects Does ENZALUTAMIDE Cause?
Fatigue (8,891)
Death (6,680)
Malignant neoplasm progression (4,696)
Prostatic specific antigen increased (3,731)
Asthenia (3,589)
Drug ineffective (3,468)
Hot flush (3,144)
Decreased appetite (3,069)
Nausea (2,898)
Dizziness (2,776)
What Other Drugs Cause Neuropathy peripheral?
LENALIDOMIDE (10,215)
BORTEZOMIB (4,067)
OXALIPLATIN (3,662)
DEXAMETHASONE (3,543)
PACLITAXEL (3,508)
LEVOFLOXACIN (2,619)
CIPROFLOXACIN (2,607)
FLUOROURACIL (2,605)
CYCLOPHOSPHAMIDE (2,565)
POMALIDOMIDE (2,382)
Which ENZALUTAMIDE Alternatives Have Lower Neuropathy peripheral Risk?
ENZALUTAMIDE vs EPCORITAMAB
ENZALUTAMIDE vs EPCORITAMAB-BYSP
ENZALUTAMIDE vs EPERISONE
ENZALUTAMIDE vs EPHEDRINE
ENZALUTAMIDE vs EPINASTINE